Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Study of Escitalopram Versus Risperidone for the Treatment of Behavioral and Psychological Symptoms Amongst Alzheimer's Disease Patients

NCT01119638 is registered in ClinicalTrials.gov with Abarbanel Mental Health Center as lead sponsor.

NCT NCT01119638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01119638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Study of Escitalopram Versus Risperidone for the Treatment of Behavioral and Psychological Symptoms Amongst Alzheimer's Disease Patients
Lead sponsor
Abarbanel Mental Health Center
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2008
Completion date
May 31, 2010
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agitation, alzheimer's disease, psychosis